Science
Mechanism of Action
Salnacedin (G-201) operates through a dual mechanism, exhibiting both anti-inflammatory and keratolytic properties. These actions indicate a potential for moderating inflammatory responses and promoting the exfoliation of dead skin cells, which are relevant in the pathogenesis of conditions like seborrhoeic dermatitis and acne.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
Salnacedin is not commonly used in cosmetic formulations and is primarily designated for research purposes, making 'dusting' considerations irrelevant.
The Formula
Formulation
Safety
Safety Profile
Salnacedin is currently sold exclusively for research applications and is not marketed directly to patients. A formal safety review by the CIR (Cosmetic Ingredient Review) has not been conducted.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Due to its designation as a research-use-only compound and the absence of comprehensive clinical efficacy and safety data for cosmetic applications, Salnacedin is not recommended for formulation at this time.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources